{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T22:44:11Z","timestamp":1789425851691,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T00:00:00Z","timestamp":1684108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T00:00:00Z","timestamp":1684108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Major Project of Wenzhou Science and Technology Bureau","award":["ZY2022016"],"award-info":[{"award-number":["ZY2022016"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiol med"],"DOI":"10.1007\/s11547-023-01646-1","type":"journal-article","created":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T16:12:13Z","timestamp":1684167133000},"page":"679-688","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Evaluation the benefits of additional radiotherapy for gastric cancer patients after D2 resection using CT based radiomics"],"prefix":"10.1007","volume":"128","author":[{"given":"Haoze","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ce","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinling","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4117-5953","authenticated-orcid":false,"given":"Xiance","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,15]]},"reference":[{"issue":"6","key":"1646_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"1646_CR2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40880-019-0372-x","volume":"39","author":"K Gao","year":"2019","unstructured":"Gao K, Wu J (2019) National trend of gastric cancer mortality in China (2003\u20132015): a population-based study. Cancer Commun (Lond) 39(1):24. https:\/\/doi.org\/10.1186\/s40880-019-0372-x","journal-title":"Cancer Commun (Lond)"},{"issue":"9813","key":"1646_CR3","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0140-6736(11)61873-4","volume":"379","author":"YJ Bang","year":"2012","unstructured":"Bang YJ, Kim YW, Yang HK et al (2012) Adjustment capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet 379(9813):315\u2013321. https:\/\/doi.org\/10.1016\/S0140-6736(11)61873-4","journal-title":"Lancet"},{"issue":"1","key":"1646_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10120-016-0622-4","volume":"20","author":"JGC Association","year":"2017","unstructured":"Association JGC (2017) Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer 20(1):1\u201319. https:\/\/doi.org\/10.1007\/s10120-016-0622-4","journal-title":"Gastric Cancer"},{"key":"1646_CR5","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1056\/NEJMoa072252","volume":"357","author":"S Sakuramoto","year":"2007","unstructured":"Sakuramoto S, Sasako M, Yamaguchi T et al (2007) Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 357:1810\u20131820. https:\/\/doi.org\/10.1056\/NEJMoa072252","journal-title":"N Engl J Med"},{"key":"1646_CR6","doi-asserted-by":"publisher","first-page":"4387","DOI":"10.1200\/JCO.2011.36.5908","volume":"29","author":"M Sasako","year":"2011","unstructured":"Sasako M, Sakuramoto S, Katai H et al (2011) Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. J Clin Oncol 29:4387\u20134393. https:\/\/doi.org\/10.1200\/JCO.2011.36.5908","journal-title":"J Clin Oncol"},{"issue":"10","key":"1646_CR7","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1056\/NEJMoa010187","volume":"345","author":"JS Macdonald","year":"2001","unstructured":"Macdonald JS, Smalley SR, Benedetti J et al (2001) Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345(10):725\u2013730. https:\/\/doi.org\/10.1056\/NEJMoa010187","journal-title":"N Engl J Med"},{"issue":"19","key":"1646_CR8","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1200\/JCO.2011.36.7136","volume":"30","author":"SR Smalley","year":"2012","unstructured":"Smalley SR, Benedetti JK, Haller DG et al (2012) Updated analysis of SWOG-directed Intergroup Study 0116: a Phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection. J Clin Oncol 30(19):2327\u20132333. https:\/\/doi.org\/10.1200\/JCO.2011.36.7136","journal-title":"J Clin Oncol"},{"issue":"3","key":"1646_CR9","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.annonc.2020.11.017","volume":"32","author":"SH Park","year":"2021","unstructured":"Park SH, Lim DH, Sohn TS et al (2021) ARTIST 2 investigators. A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial. Ann Oncol 32(3):368\u2013374. https:\/\/doi.org\/10.1016\/j.annonc.2020.11.017","journal-title":"Ann Oncol"},{"issue":"5","key":"1646_CR10","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1097\/01.sla.0000143245.28656.15","volume":"240","author":"M D'Angelica","year":"2004","unstructured":"D\u2019Angelica M, Gonen M, Brennan MF, Turnbull AD, Bains M, Karpeh MS (2004) Patterns of initial recurrence in completely resected gastric adenocarcinoma. Ann Surg 240(5):808\u2013816. https:\/\/doi.org\/10.1097\/01.sla.0000143245.28656.15","journal-title":"Ann Surg"},{"issue":"4","key":"1646_CR11","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1002\/jso.25639","volume":"120","author":"T Son","year":"2019","unstructured":"Son T, Sun J, Choi S et al (2019) Multi-institutional validation of the 8th AJCC TNM staging system for gastric cancer: analysis of survival data from high-volume eastern centers and the SEER database. J Surg Oncol 120(4):676\u2013684. https:\/\/doi.org\/10.1002\/jso.25639","journal-title":"J Surg Oncol"},{"issue":"12","key":"1646_CR12","doi-asserted-by":"publisher","first-page":"3683","DOI":"10.1245\/s10434-017-6078-x","volume":"24","author":"H In","year":"2017","unstructured":"In H, Solsky I, Palis B, Langdon-Embry M, Ajani J, Sano T (2017) Validation of the 8th edition of the AJCC TNM staging system for gastric cancer using the national cancer database. Ann Surg Oncol 24(12):3683\u20133691. https:\/\/doi.org\/10.1245\/s10434-017-6078-x","journal-title":"Ann Surg Oncol"},{"key":"1646_CR13","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ebiom.2017.06.028","volume":"22","author":"Y Jiang","year":"2017","unstructured":"Jiang Y, Liu W, Li T et al (2017) Prognostic and predictive value of p21-activated kinase 6 associated support vector machine classifier in gastric cancer treated by 5-fluorouracil\/oxaliplatin chemotherapy. EBioMedicine 22:78\u201388. https:\/\/doi.org\/10.1016\/j.ebiom.2017.06.028","journal-title":"EBioMedicine"},{"issue":"22","key":"1646_CR14","doi-asserted-by":"publisher","first-page":"5574","DOI":"10.1158\/1078-0432.CCR-18-0848","volume":"24","author":"Y Jiang","year":"2018","unstructured":"Jiang Y, Xie J, Han Z et al (2018) Immunomarker support vector machine classifier for prediction of gastric cancer survival and adjuvant chemotherapeutic benefit. Clin Cancer Res 24(22):5574\u20135584. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-0848","journal-title":"Clin Cancer Res"},{"issue":"2","key":"1646_CR15","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1148\/radiol.2015151169","volume":"278","author":"RJ Gillies","year":"2016","unstructured":"Gillies RJ, Kinahan PE, Hricak H (2016) Radiomics: images are more than pictures, they are data. Radiology 278(2):563\u2013577. https:\/\/doi.org\/10.1148\/radiol.2015151169","journal-title":"Radiology"},{"key":"1646_CR16","doi-asserted-by":"publisher","first-page":"4006","DOI":"10.1038\/ncomms5006","volume":"5","author":"HJ Aerts","year":"2014","unstructured":"Aerts HJ, Velazquez ER, Leijenaar RT et al (2014) Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun 5:4006. https:\/\/doi.org\/10.1038\/ncomms5006","journal-title":"Nat Commun"},{"key":"1646_CR17","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ebiom.2018.09.007","volume":"36","author":"Y Jiang","year":"2018","unstructured":"Jiang Y, Chen C, Xie J et al (2018) Radiomics signature of computed tomography imaging for prediction of survival and chemotherapeutic benefits in gastric cancer. EBioMedicine 36:171\u2013182. https:\/\/doi.org\/10.1016\/j.ebiom.2018.09.007","journal-title":"EBioMedicine"},{"issue":"1","key":"1646_CR18","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1186\/s12885-020-06970-7","volume":"20","author":"KY Sun","year":"2020","unstructured":"Sun KY, Hu HT, Chen SL et al (2020) CT-based radiomics scores predict response to neoadjuvant chemotherapy and survival in patients with gastric cancer. BMC Cancer 20(1):468. https:\/\/doi.org\/10.1186\/s12885-020-06970-7","journal-title":"BMC Cancer"},{"issue":"4","key":"1646_CR19","doi-asserted-by":"publisher","first-page":"727","DOI":"10.4143\/crt.2014.018","volume":"47","author":"JA Lee","year":"2015","unstructured":"Lee JA, Ahn YC, Lim DH, Park HC, Asranbaeva MS (2015) Dosimetric and clinical influence of 3D versus 2D planning in postoperative radiation therapy for gastric cancer. Cancer Res Treat 47(4):727\u2013737. https:\/\/doi.org\/10.4143\/crt.2014.018","journal-title":"Cancer Res Treat"},{"issue":"16","key":"1646_CR20","doi-asserted-by":"publisher","first-page":"4786","DOI":"10.1158\/0008-5472.CAN-18-0125","volume":"78","author":"C Nioche","year":"2018","unstructured":"Nioche C, Orlhac F, Boughdad S et al (2018) LIFEx: a freeware for radiomic feature calculation in multimodality imaging to accelerate advances in the characterization of tumor heterogeneity. Cancer Res 78(16):4786\u20134789. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-0125","journal-title":"Cancer Res"},{"issue":"21","key":"1646_CR21","doi-asserted-by":"publisher","first-page":"e104","DOI":"10.1158\/0008-5472.CAN-17-0339","volume":"77","author":"JJM van Griethuysen","year":"2017","unstructured":"van Griethuysen JJM, Fedorov A, Parmar C et al (2017) Computational radiomics system to decode the radiographic phenotype. Cancer Res 77(21):e104\u2013e107. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-0339","journal-title":"Cancer Res"},{"issue":"3","key":"1646_CR22","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1080\/03610918.2019.1571605","volume":"50","author":"JC Utazirubanda","year":"2021","unstructured":"Utazirubanda JC, Leon T, Ngom P (2021) Variable selection with group LASSO approach: application to Cox regression with frailty model. Commun Stat Simul Comput 50(3):881\u2013901. https:\/\/doi.org\/10.1080\/03610918.2019.1571605","journal-title":"Commun Stat Simul Comput"},{"key":"1646_CR23","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jspi.2013.12.002","volume":"148","author":"T Honda","year":"2014","unstructured":"Honda T, Hardle WK (2014) Variable selection in Cox regression models with varying coefficients. J Stat Plan Inference 148:67\u201381. https:\/\/doi.org\/10.1016\/j.jspi.2013.12.002","journal-title":"J Stat Plan Inference"},{"issue":"21","key":"1646_CR24","doi-asserted-by":"publisher","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","volume":"10","author":"RL Camp","year":"2004","unstructured":"Camp RL, Dolled-Filhart M, Rimm DL (2004) X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res 10(21):7252\u20137259. https:\/\/doi.org\/10.1158\/1078-0432.CCR-04-0713","journal-title":"Clin Cancer Res"},{"key":"1646_CR25","doi-asserted-by":"publisher","first-page":"725889","DOI":"10.3389\/fonc.2021.725889","volume":"11","author":"D Hao","year":"2022","unstructured":"Hao D, Li Q, Feng QX et al (2022) Identifying prognostic markers from clinical, radiomics, and deep learning imaging features for gastric cancer survival prediction. Front Oncol 11:725889. https:\/\/doi.org\/10.3389\/fonc.2021.725889","journal-title":"Front Oncol"},{"key":"1646_CR26","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1200\/JCO.2011.39.1953","volume":"29","author":"J Lee","year":"2011","unstructured":"Lee J, Lim DH, Kim S et al (2011) Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST Trial. J Clin Oncol 29:269\u2013273. https:\/\/doi.org\/10.1200\/JCO.2011.39.1953","journal-title":"J Clin Oncol"},{"key":"1646_CR27","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.1200\/JCO.2014.58.3930","volume":"33","author":"SH Park","year":"2015","unstructured":"Park SH, Sohn TS, Lee J et al (2015) Phase III trial to compare adjuvant chemotherapy with capecitabine and cisplatin versus concurrent chemoradiotherapy in gastric cancer: final report of the adjuvant chemoradiotherapy in stomach tumors trial, including survival and subset analysis. J Clin Oncol 33:3130\u20133136. https:\/\/doi.org\/10.1200\/JCO.2014.58.3930","journal-title":"J Clin Oncol"},{"key":"1646_CR28","doi-asserted-by":"publisher","first-page":"110393","DOI":"10.1016\/j.ejrad.2022.110393","volume":"154","author":"H Zheng","year":"2022","unstructured":"Zheng H, Zheng Q, Jiang M et al (2022) Contrast-enhanced CT based radiomics in the preoperative prediction of perineural invasion for patients with gastric cancer. Eur J Radiol 154:110393. https:\/\/doi.org\/10.1016\/j.ejrad.2022.110393","journal-title":"Eur J Radiol"},{"issue":"6","key":"1646_CR29","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1007\/BF02573892","volume":"9","author":"WJ Hyung","year":"2002","unstructured":"Hyung WJ, Lee JH, Choi SH, Min JS, Noh SH (2002) Prognostic impact of lymphatic and\/or blood vessel invasion in patients with node-negative advanced gastric cancer. Ann Surg Oncol 9(6):562\u2013567. https:\/\/doi.org\/10.1007\/BF02573892","journal-title":"Ann Surg Oncol"}],"container-title":["La radiologia medica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-023-01646-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11547-023-01646-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-023-01646-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T17:09:41Z","timestamp":1686676181000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11547-023-01646-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,15]]},"references-count":29,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["1646"],"URL":"https:\/\/doi.org\/10.1007\/s11547-023-01646-1","relation":{},"ISSN":["1826-6983"],"issn-type":[{"value":"1826-6983","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,15]]},"assertion":[{"value":"23 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted in accordance with the principles of the Declaration of Helsinki and approved by the institutional Ethics Committee in Clinical Research (ECCR).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was waived by the ECCR due to the retrospectively nature of this study (ECCR no. 2019059).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The data of the individual (including any personal details, images or videos) in the manuscript have been obtained with the consent of the individual or the child, their parent or legal guardian.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}